The last publications of Gercor are:
- C. Tournigand et al. FOLFIRI followed by FOLFOX 6 or the reverse sequence in advanced colorectal cancer. A randomized Gercor study. J Clin Oncol., 2004, in press
- T. André et al. Semi monthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer :
results of a randomized trial. J Clin Oncol., 2003; 21: 2896-903 - C. Louvet et al. Phase II study of oxaliplatin, fluorouracil,
and folinic acid in locally advanced or metastatic gastric
cancer patients. J Clin Oncol., 2002; 20: 4543-48 - C. Louvet et al. Gemcitabine combined with oxaliplatin in
advanced pancreatic carcinoma : final results of a Gercor
multicenter phase II study. J Clin Oncol., 2002; 20: 1512-18 - A. de Gramont et al. Leucovorin and fluorouracil with or without oxaliplatin as first line treatment in advanced colorectal cancer. J Clin Oncol., 2000; 18: 2938-47